Results Announcements News Details
Tatva Chintan Pharma Chem consolidated net profit rises 901.94% in the March 2026 quarter
(18-May-26 07:26)
Net profit of Tatva Chintan Pharma Chem rose 901.94% to Rs 10.32 crore in the quarter ended March 2026 as against Rs 1.03 crore during the previous quarter ended March 2025. Sales rose 24.36% to Rs 134.14 crore in the quarter ended March 2026 as against Rs 107.86 crore during the previous quarter ended March 2025.
For the full year,net profit rose 636.43% to Rs 42.05 crore in the year ended March 2026 as against Rs 5.71 crore during the previous year ended March 2025. Sales rose 32.18% to Rs 505.86 crore in the year ended March 2026 as against Rs 382.71 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 134.14 | 107.86 | 24 | 505.86 | 382.71 | 32 |
| OPM % | 20.97 | 8.30 | - | 18.42 | 8.94 | - |
| PBDT | 26.34 | 9.29 | 184 | 93.86 | 35.24 | 166 |
| PBT | 16.59 | 2.03 | 717 | 57.01 | 7.58 | 652 |
| NP | 10.32 | 1.03 | 902 | 42.05 | 5.71 | 636 |
Powered by Capital Market - Live News
